Evidence map›Paper›PMID 28371917›Full record

ArticleThe international journal of neuropsychopharmacology2017

Response to Dr. Okumura.

Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, Toshiya Inada, Takashi Yoshio, Reiji Yoshimura, Nakao Iwata

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Yoshio YamanouchiDepartment of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan; National Hospital Organization, Tottori Medical Center, Tottori, Japan; School of International Politics, Economics and Communication, Aoyama Gakuin University, Tokyo, Japan; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan; Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Tsuruhei Sukegawa
Ataru InagakiDepartment of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan; National Hospital Organization, Tottori Medical Center, Tottori, Japan; School of International Politics, Economics and Communication, Aoyama Gakuin University, Tokyo, Japan; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan; Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Toshiya InadaDepartment of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan; National Hospital Organization, Tottori Medical Center, Tottori, Japan; School of International Politics, Economics and Communication, Aoyama Gakuin University, Tokyo, Japan; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan; Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Takashi YoshioDepartment of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan; National Hospital Organization, Tottori Medical Center, Tottori, Japan; School of International Politics, Economics and Communication, Aoyama Gakuin University, Tokyo, Japan; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan; Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Reiji YoshimuraDepartment of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan; National Hospital Organization, Tottori Medical Center, Tottori, Japan; School of International Politics, Economics and Communication, Aoyama Gakuin University, Tokyo, Japan; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan; Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
Nakao IwataDepartment of Mental Health Policy and Evaluation, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan; National Hospital Organization, Tottori Medical Center, Tottori, Japan; School of International Politics, Economics and Communication, Aoyama Gakuin University, Tokyo, Japan; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan; Department of Psychiatry, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28371917
PMCPMC5492779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.